2 months ago
FOLD
AnalystsTazeen AhmadTazeen Ahmad's Stock Forecasts
AnalystsTazeen Ahmad
Analyst Ranking
Bottom 13%
#4152 out of 4754 analysts
Average Return
-0.37%
Win Rate
47%60 out of 129
Risk vs Reward
Poor
Good
Tazeen Ahmad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +339.08% | $20.01 | $87.86 | 2019-12-20 - 2020-10-22 | Strong Buy |
Argenx SeARGX | +133.81% | $157.46 | $368.16 | 2020-02-10 - 2021-02-10 | Strong Buy |
Avexis IncAVXS | +127.40% | $95.79 | $217.83 | 2017-11-10 - 2018-05-15 | Strong Buy |
Ascendis Pharma AASND | +109.30% | $71.43 | $149.50 | 2023-04-04 - 2024-04-03 | Strong Buy |
Acadia Pharmaceuticals IncACAD | +100.00% | $20.24 | $40.48 | 2018-10-10 - 2019-10-10 | Strong Buy |
Tazeen Ahmad Analyst Color
Get additional color on Tazeen Ahmad's coverage of popular stocks
a year ago
RYTM
a year ago
APLS
a year ago
FDMT
2 years ago
SRPT
2 years ago
GRTX
2 years ago
PRTA
3 years ago
ASND
Tazeen Ahmad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pepgen IncPEPG | 2 | Hold | $6.00 | -0.17% | Maintains | 17 days ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Buy | $47.00 | +37.71% | Maintains | a month ago |
Incyte CorpINCY | 5 | Strong Buy | $90.00 | +20.61% | Upgrades | a month ago |
Amicus Therapeutics IncFOLD | 3 | Strong Buy | $15.00 | +52.13% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $314.00 | +23.27% | Maintains | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 7 | Hold | $52.00 | -13.86% | Maintains | 2 months ago |
Sage Therapeutics IncSAGE | 13 | Sell | $6.00 | +6.95% | Maintains | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 4 | Hold | $31.00 | +113.35% | Maintains | 2 months ago |
Ascendis Pharma AASND | 7 | Strong Buy | $191.00 | +45.79% | Maintains | 2 months ago |
Biontech SeBNTX | 6 | Strong Buy | $150.00 | +30.78% | Maintains | 3 months ago |
Fulcrum Therapeutics IncFULC | 4 | Sell | $2.00 | -43.02% | Downgrades | 3 months ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $29.00 | +22.36% | Maintains | 3 months ago |
Merus NvMRUS | 4 | Strong Buy | $76.00 | +67.09% | Maintains | 5 months ago |
Argenx SeARGX | 3 | Strong Buy | $607.00 | -2.87% | Reiterates | 5 months ago |
Ptc Therapeutics IncPTCT | 10 | Sell | $32.00 | -35.82% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 21 | Strong Buy | $213.00 | +68.34% | Maintains | 5 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $76.00 | +61.32% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Hold | $22.00 | +28.13% | Maintains | 7 months ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $12.00 | +322.54% | Initiates Coverage On | 7 months ago |
Inozyme Pharma IncINZY | 2 | Strong Buy | $14.00 | +420.45% | Maintains | 8 months ago |
Annexon IncANNX | 4 | Strong Buy | $10.00 | +93.80% | Maintains | 8 months ago |
Fate Therapeutics IncFATE | 2 | Sell | $6.00 | +134.38% | Maintains | 8 months ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $15.00 | +58.23% | Initiates Coverage On | 10 months ago |
Cyteir Therapeutics IncCYTT | 2 | Sell | $3.00 | -0.66% | Downgrades | a year ago |
Achilles Therapeutics PLCACHL | 1 | Sell | $0.50 | -53.05% | Downgrades | a year ago |
Pharvaris NvPHVS | 3 | Sell | $11.00 | -45.00% | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $31.00 | N/A | Downgrades | a year ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Strong Buy | $10.00 | N/A | Upgrades | a year ago |
4d Molecular Therapeutics IncFDMT | 2 | Strong Buy | $33.00 | N/A | Maintains | a year ago |
Adc Therapeutics SaADCT | 2 | Sell | $2.00 | N/A | Downgrades | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Strong Buy | $7.00 | N/A | Upgrades | 2 years ago |
Sqz Biotechnologies CoSQZB | 2 | Sell | $2.00 | N/A | Downgrades | 2 years ago |
Prelude Therapeutics IncPRLD | 4 | Sell | $6.00 | N/A | Downgrades | 2 years ago |
Surrozen IncSRZN | 3 | Sell | $15.00 | N/A | Downgrades | 2 years ago |
Praxis Precision Medicines IncPRAX | 2 | Hold | $60.00 | N/A | Downgrades | 2 years ago |
Molecular Templates IncMTEM | 2 | Sell | $22.50 | N/A | Downgrades | 3 years ago |
Pyxis Oncology IncPYXS | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Quince Therapeutics IncQNCX | 1 | Sell | N/A | N/A | Downgrades | 3 years ago |
Arvinas IncARVN | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 3 years ago |
Akouos IncAKUS | 2 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Orphazyme AORPHY | 1 | Sell | $5.00 | N/A | Downgrades | 4 years ago |
89bio IncETNB | 1 | Strong Buy | $43.00 | N/A | Upgrades | 4 years ago |
Clovis Oncology IncCLVSQ | 1 | Sell | $6.00 | N/A | Downgrades | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Dbv Technologies SaDBVT | 1 | Strong Buy | $300.00 | N/A | Maintains | 6 years ago |
Tesaro IncTSRO | 4 | Hold | $39.00 | N/A | Maintains | 6 years ago |
Spero Therapeutics IncSPRO | 2 | Sell | $9.00 | N/A | Downgrades | 6 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $48.00 | N/A | Maintains | 6 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $25.00 | N/A | Downgrades | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Strong Buy | $200.00 | N/A | Maintains | 6 years ago |
Ptc IncPTC | 3 | Hold | $102.00 | N/A | Maintains | 6 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $102.00 | N/A | Maintains | 7 years ago |
Seagen IncSGEN | 1 | Hold | $68.00 | N/A | Maintains | 7 years ago |
Avexis IncAVXS | 1 | Strong Buy | $112.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.